This program project proposal on Alzheimer's Disease (AD) contains a Core and three research proposals. The major aim of this proposal is to investigate pathogenetic mechanisms in AD. This study will investigate trace element neurotoxicity, the serotonin hypothesis in AD and defective microtubule assembly in AD. The Core will function to 1) acquire and evaluate tissue from clinically thoroughly studied patients with AD, other CNS degenerative diseases and normal controls, 2) act as a central coordinating unit for the research project and 3) provide administrative supervision for the project. Project #1 tests the hypothesis that there are neurotoxic trace elements or imbalances of elements in AD that play a role in the degenerative changes in the brain. This project will use a new state-of-the-art LAMMA 500 laser activated microprobe mass analyzer, electron microscope with integrated electron energy loss spectrometry, instrumental neutron activation analysis and atomic absorption spectroscopy to study trace elements at the bulk, cellular and ultrastructural level in multiple brain regions and extra-neural tissue in AD and normal controls and brains of other CNS degenerative diseases. Project #2 addresses the interrelationship between serotonin, acetylcholine and AD pathological alterations in the amygdala and other brain regions. Serotonin content, uptake synthesis oxidation and subtype binding, other monoamine activity and acetylcholine binding synthesis and degradation will be correlated with quantification of neuron number, and NFT and SP counts. Project #3 is aimed at defining the mechanism of defective brain microtubule assembly in AD. Preliminary results have shown that a soluble factor in the frontal lobe of the AD brain blocks or modifies the GTP binding site on B-tubulin. Studies using photoaffinity probes will be aimed at defining if this alteration is present in other region of the AD brain or other CNS degenerative disorders with cytoskeletal alterations. Other studies will isolate and characterize this blocking factor. The differences in the ATP phosphorylation profile in AD will be investigated, in addition to studies to determine if there are differences in cAMP and cGMP protein kinases in AD and control brains.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG005119-08
Application #
3090974
Study Section
Aging Review Committee (AGE)
Project Start
1984-12-01
Project End
1994-04-30
Budget Start
1992-05-15
Budget End
1993-04-30
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Ding, Qunxing; Zhu, Haiyan (2018) Upregulation of PSMB8 and cathepsins in the human brains of dementia with Lewy bodies. Neurosci Lett 678:131-137
Ellison, Elizabeth M; Abner, Erin L; Lovell, Mark A (2017) Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease. J Neurochem 140:383-394
Hartz, Anika M S; Zhong, Yu; Wolf, Andrea et al. (2016) A?40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. J Neurosci 36:1930-41
Butterfield, D Allan; Palmieri, Erika M; Castegna, Alessandra (2016) Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Rev Proteomics 13:259-74
Bradley-Whitman, Melissa A; Lovell, Mark A (2015) Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Arch Toxicol 89:1035-44
Barone, Eugenio; Cenini, Giovanna; Di Domenico, Fabio et al. (2015) Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53. J Neurosci Res 93:1728-39
Di Domenico, Fabio; Pupo, Gilda; Mancuso, Cesare et al. (2015) Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease. J Alzheimers Dis 44:1107-20
Chen, Chun-Hau; Li, Wenzong; Sultana, Rukhsana et al. (2015) Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease. Neurobiol Dis 76:13-23
Lovell, Mark A; Abner, Erin; Kryscio, Richard et al. (2015) Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxid Med Cell Longev 2015:787805
Sethi, M; Joshi, S S; Webb, R L et al. (2015) Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer's disease. Neuroscience 290:80-9

Showing the most recent 10 out of 244 publications